Zealand Pharma A/S
ZLDPF News Today: Stay Updated with the Latest Zealand Pharma A/S News in Real Time
Find ZLDPF news now at Meyka AI. Stay informed with the latest Zealand Pharma A/S stocks updates, including price news, market analysis, and expert insights.
XtalPi Holdings Ltd Slips 3.3% as AI Drug Discovery Faces Valuation Pressure
2228.HK stock drops 3.3% to HK$7.9 amid sector headwinds. XtalPi Holdings faces valuation challenges despite AI-driven drug discovery focus.
Innlanz Limited (INL.AX) Drops 10% on Heavy Volume Spike
INL.AX stock falls 10% with trading volume surging 63x average. Hotel operator faces ongoing financial headwinds in pre-market session.
Metro Performance Glass Limited (MPP.AX) Faces Earnings Test as Stock Trades at A$0.80
MPP.AX stock trades at A$0.80 ahead of May 25 earnings. Glass supplier reports negative earnings with construction sector headwinds.
Pacific Edge Limited (PEB.AX) Slips 2.1% as Earnings Loom
PEB.AX stock falls 2.1% to A$0.23 ahead of May 24 earnings announcement. Cancer diagnostics firm faces profitability challenges.
EROAD Limited Slips 1.8% as Earnings Loom on May 25
ERD.AX stock falls 1.8% to A$0.80 ahead of May 25 earnings announcement. Fleet management software firm faces profitability challenges.
Bristol-Myers Squibb Stock Drops 4.4% on Valuation Pressure
BMY.SW stock falls 4.4% to CHF42.54 on SIX. Pharma giant faces valuation headwinds despite strong dividend yield and upcoming earnings.
Eli Lilly Stock Surges 10.2% on Strong Earnings Growth and Pharma Momentum
LLY.SW stock jumps 10.2% to CHF755 on SIX. Eli Lilly reports strong earnings growth and maintains healthcare sector leadership with robust pipeline.
NSRX Insider Trade: CFO Rubin Eyal Options Filing May 20, 2026
Nasus Pharma CFO Rubin Eyal files initial ownership of 40,549 share options worth $306,550. Form 3 filing reveals executive equity stake.
Pro-Pac Packaging Limited (PPG.AX) Holds Steady at A$0.018 Amid Sector Headwinds
PPG.AX stock trades flat at A$0.018 on ASX. Meyka AI rates the packaging company C+ with a Hold recommendation amid structural challenges.